LINC Stock Overview
A private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Linc AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 91.80 |
| 52 Week High | SEK 103.40 |
| 52 Week Low | SEK 52.20 |
| Beta | 0.97 |
| 11 Month Change | 2.80% |
| 3 Month Change | 4.20% |
| 1 Year Change | 46.65% |
| 33 Year Change | 7.75% |
| 5 Year Change | n/a |
| Change since IPO | 8.00% |
Recent News & Updates
Shareholder Returns
| LINC | SE Capital Markets | SE Market | |
|---|---|---|---|
| 7D | 9.5% | 6.8% | 1.4% |
| 1Y | 46.6% | 58.9% | 20.2% |
Return vs Industry: LINC underperformed the Swedish Capital Markets industry which returned 53.7% over the past year.
Return vs Market: LINC exceeded the Swedish Market which returned 19.4% over the past year.
Price Volatility
| LINC volatility | |
|---|---|
| LINC Average Weekly Movement | 4.8% |
| Capital Markets Industry Average Movement | 4.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 12.0% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: LINC has not had significant price volatility in the past 3 months.
Volatility Over Time: LINC's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 2 | Karl Tobieson | linc.se |
Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies.
Linc AB Fundamentals Summary
| LINC fundamental statistics | |
|---|---|
| Market cap | SEK 5.32b |
| Earnings (TTM) | SEK 1.55b |
| Revenue (TTM) | SEK 1.56b |
3.4x
P/E Ratio3.4x
P/S RatioIs LINC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LINC income statement (TTM) | |
|---|---|
| Revenue | SEK 1.56b |
| Cost of Revenue | SEK 0 |
| Gross Profit | SEK 1.56b |
| Other Expenses | SEK 7.27m |
| Earnings | SEK 1.55b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 26.83 |
| Gross Margin | 100.00% |
| Net Profit Margin | 99.53% |
| Debt/Equity Ratio | 0% |
How did LINC perform over the long term?
See historical performance and comparison